Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
247 Cards in this Set
- Front
- Back
What is the most common cause of iron-deficiency anemia in premenopausal women?
|
menstrual blood loss
|
|
What is the most common cause of iron-deficiency anemia in post-menopausal women?
|
occult blood loss through GI bleeding
|
|
Ferrous sulfate tablets are _____ supplements.
Which is the most commonly used form? |
oral iron;
an immediate release ferrous sulfate generic preparation |
|
What is the dosage of Ferrous Sulfate tablets?
What are some common ADRs? |
325mg TID between meals;
constipation, darkened stools, nasuea, epigastric pain |
|
_____therapy darkens stools.
|
oral iron
|
|
When taking oral iron supplements and al-mg hydroxide antacids, want to take the iron at least ____ hour(s) before or ___ hour(s) after the antacid.
Ferrous ion reacts with hydroxide to form........ |
1;3;
insoluble complexes |
|
Antacids or H2RAs cause a _______ in epigastric pH which results in a ________ solubility of iron salts from iron supplements.
|
increased; decreased
|
|
Iron greatly decreases _____ absorption, through a chelation interaction.
|
tetracycline
|
|
Iron Dextran is a _______ form of iron supplementation.
It is a ______ molecular weight form of iron. |
parenteral;
higher |
|
When using Iron Dextran, need to be cautious about ________ because it can cause a potentially _____________ reaction. Due to this, _______ is required.
|
hypersensitivity;
fatal anaphylactic; a test dose |
|
ADR's are more common in which form of iron supplementation?
|
high molecular weight iron (iron dextran)
|
|
Delayed reactions at ____-____ hours after recommended doses of Iron Dextran have been reported.
|
24-48
|
|
Iron dextran is not recommend for its with ____, ____ or ____.
|
CKD, cancer- or chemo-induced anemia
|
|
When injecting Iron Dextran, only want to inject it into the _______ of the _______. Never inject it into......
Give by deep injection using the ____ Technique to avoid.... |
muscle mass; upper outer quad of the butt;
the arm or exposed area; z track; leakage into SC tissue and staining of the skin |
|
What are three major causes of folic acid deficiency?
|
alcoholism due to poor nutrition, any condition of rapid cell turnover (malignancy), and malabsorption syndromes
|
|
What is a contraindication for the treatment of folic acid deficiency?
This is because treating with large doses of folate can reverse the hematologic abnormalities but does nothing to correct the _________ damage associated with the B12 deficiency, and it will continue to progress. |
treatment of pernicious anemia when B12 is deficient;
neurologic |
|
If the folic acid deficiency is caused by a ______ inhibitor, then use __________.
This drug is a form of folic acid that does not require...... |
DHFR; leucovorin calcium (folinic acid);
DHFR for conversion to the active form, bypassing the inhibited DHFR |
|
The enzyme __________ is needed to convert dietary or supplemental folic acid to the biologically active forms of folate required for DNA synthesis.
|
dihydrofolate reductase (DHFR
|
|
Epoetin alfa is a ______ manufactured through recombinant DNA technology and has the same actions as ______.
Indicated for: (3) Contraindicated in ________ |
glycoprotien;
erythropoietin; anemia associated with CKD, Anemia related to zidovudine (tx in HIV pts), and chemo-induced anemia; uncontrolled HTN |
|
When hemodialysis pts are on epoetin alfa, _____ iron supplements have been reported to fail to maintain adequate iron stores.
Many CKD pts and almost all hemodialysis pts will require ____ iron supplementation |
oral;
parenteral |
|
FDA recommends a target Hbg in the range of ______ when using Epoetin alfa. When exceeds ____g/dL, risk of serious _______ and ______ increases
|
10-12 g/dL;
12; CV events and death |
|
What are the 4 clinical uses for glucocorticoids?
|
adrenal insufficiency (replacement tx), tx of chronic inflammatory dz such as RA, tx of allergic rxns, and immunosuppression (during transplantation)
|
|
What are (4) adverse drug reactions of glucocorticoids?
|
osteoporosis, peptic ulceration/gastric bleeding, cataracts, suppression of the HPA axis
|
|
What is the main glucocorticoid?
|
prednisone
|
|
Cyclooxygenase 2 (COX2) is an inducible enzyme produced in response to.........
Now known to be involved in normal mechanism for normal ____ function, _____ integrity, and ____ function. |
external stimuli (tissue damage, inflammation);
renal; GIT; platelet |
|
PGE2 is the major PG involved in...
|
the inflammatory process
|
|
During acute and chronic inflammation, PGE2 is produced by _____ Resulting in ___ and ___
|
COX2; pain, vasodilation
|
|
PGE2 produced in the gastric mucosa is produced by _____
|
COX1
|
|
In the renal cortex, _____ and ____ Are both present, but ____ predominates. ____ is needed for normal kidney function.
PGE2 and PGI2 produced in the kidney cause renal ____ and maintain _______. |
COX1; COX2;
COX1; COX2; vasodilation; perfusion |
|
In platelets, COX1 stimulates....
|
TXA2-induced platelet aggregation.
|
|
Nonselective NSAIDs inhibit both ____, ____ and ____ causing....(6)
|
COX1, COX2 and thromboxane synthetase;
antiinflammatory, analgesic, antipyretic effects, decrease gastric mucosal protection and increase risk of ulceration, decreased renal perfusion, decreased platelet aggregation and increased bleeding tendency |
|
Theoretically, selective inhibition of COX2 would produce ____ and ____ effects with decreased risk of GI ulceration, renal toxicity and bleeding. However, clinically the only real advantage of COX2 selectivity is ________.
|
anti-inflammatory, analgesic;
the decreased GI toxicity |
|
If only using a COX2 inhibitor, the risk of heart disease or stroke would not be decreased because COX1 can still induce _______ since _____ and ____are only formed through COX1
|
platelet aggregation; TXA2; PGI2
|
|
What are 5 therapeutic effects of NSAIDs (nonselective)?
|
anti-inflammatory, analgesics, antipyretic, antiplatelet, relief of dysmenorrhea
|
|
In the GIT, NSAIDs cause a loss of ________ of PGs resulting in ____, ____ and _____.
|
cytoprotective function; irritation, peptic ulcer disease, bleeding
|
|
NSAIDS inhibit cyclooxygenase which results in decreased ______ production. Platelet aggregation is then _____ and the bleeding time is _____.
|
thomboxane; decreased; increase
|
|
PGs in the kidneys help maintain _____ And ______ especially in the presence of circulating vasoconstrictors. With diminished synthesis, ______, ______, ______ and _____ can occur.
|
adequate renal blood flow, glomerular filtration rate;
decreased GFR, ischemia, acute renal failure (renal insufficiency) and salt/water retention (hyperkalemia |
|
The risk of CHF in the elderly increases with ______ NSAID dose.
|
increased
|
|
Aspirin causes irreversible inhibition of both _____ and ____.
Effects include: (4) |
COX1 and COX2;
antiplatelet, analgesic, antipyretic, antiinflammatory |
|
Arthritic doses of aspirin can cause _______. ______ and have a direct action on the _____ center causing ___ and_____.
Contraindicated in kids due to... |
GI ulceration/bleeding; salicylism; respiratory; hyperventilation, and respiratory alkalosis;
Reyes syndrome |
|
Aspirin exacerbated respiratory disease (AERD) is an aspirin _______ and is also known as aspirin-induced ______.
Triad: _____, _____ and_______. |
sensitivity; asthma
asthma, rhinitis with nasal polyps, aspirin intolerance |
|
Aspirin causes an ____ in the anticoagulant effect of warfarin.
|
increases
|
|
Ibuprofen reduces or negates the _______ effects of ASA but not all nonselective NSAIDS exhibit this effect. _______ selective NSAIDs do not appear to interact.
|
cardioprotective; COX2
|
|
When ibuprofen is given prior to administration of aspirin, it binds reversibly to the ______ catalytic site in platelets, which ______ access to ASA. This allows ____ of ASA to occur before irreversible binding can take place.
____-specific inhibitors and _____ do not interfere with ASA binding to COX1 |
COX1; blocks; metabolism;
COX2; acetaminophen |
|
Avoid _____ when using NSAIDS because it exacerbates _____.
|
alcohol; bleeding
|
|
Nonselective NSAIDs include:
|
Aspirin, Difunisal (nonacetyl salicylates), 1st gen NSAIDs, ibuprofen, naproxen, indomethacin, piroxicam, meloxicam, phenylbutazone
|
|
Nonacetyl salicylates have a lower incidence of ______ and ____ compared to ASA.
|
GI toxicity; bleeding
|
|
Difunisal is a ________. Is 3-4x more potent than ASA as an ____ and _____.
No ____ Activity because... _____-acting than ASA |
nonacetyl salicylate;
analgesic; anti-inflammatory; antipyretic; doesn't cross BBB; longer |
|
First generation NSAIDs are used mainly for _____ effects as first line agents for relief of symptoms in ___________ states.
-Examples of conditions: (3) Avoid ______ because it exacerbates ____ and ____. Has cross-sensitivity with _____. |
anti-inflammatory; chronic inflammatory diseases
RA, acute gouty arthritis, acute ankylosing spondylitis Alcohol; GI irritation, bleeding ASA |
|
Ibuprofen is a _____ Drug indicated for ___, ____ and ___.
|
OTC NSAID; mild pain, fever, dysmenorrhea
|
|
Naproxen is a ____ Drug indicated for relief of mild-moderate ___ and ___
___ dosing due to longer half-life than ibuprofen. |
NSAID; pain, fever;
BID |
|
Indomethacin is a ____ drug with a high incidence of ________ including.... (6).
|
NSAID, adverse drug reactions.
GI bleeding and ulcers; HA's, vertigo, confusion, blood dyscrasias (neutropenia, thrombocytopenia) |
|
Piroxicam is a ____ drug that allows ___ dosing taken with the ________ because of the serious ____ toxicity.
|
NSAID; daily; largest meal; GI
|
|
Meloxicam is a ____ drug with ____ dosing. Has ___ incidence of GI toxicity and is described as '___' preferential.
|
NSAID; daily; low; COX2
|
|
Phenylbutazone is a _____ drug and is the most ____ and ___.
Long-term use has caused _____ |
NSAID; potent; dangerous;
fatal aplastic anemia |
|
Ketorolac is a _____ generation NSAID and is administered via _____ route.
|
second; parenteral
|
|
Acetaminophen is a nonopioid and nonsteroidal ____ and ____.
Is an effective alternative for ______ but is a much weaker ______ Agent (Lacks therapeutic ____ and ____ effects) |
analgesic; antipyretic;
ASA; anti-inflammatory; anti-inflammatory and antiplatelet effects. |
|
Acetaminophen has a narrow therapeutic index because it can cause ___________.
Does have a much lower incidence of ___ and _____ than ASA |
liver toxicity;
GI and hematologic disorders |
|
Hepatotoxiciy are conditions that deplete ________.
Depletion of this allows the _______ to accumulate resulting in _____, _____, _____, _____. Four causes: |
hepatic glutathione;
toxic metabolite; hepatic necrosis, jaundice, bleeding and encephalopathy; chronic high acetaminophen doses, chronic alcohol consumption, AIDS, poor nutrition |
|
About 4-6% of pts with ASA hypersensitivity are also intolerant to ______.
|
acetaminophen
|
|
Chronic ethanol ingestion can cause hepatotoxicity even when normal ____________ doses are taken.
Mechanism involves chronic alcohol-induced induction of _____ which is a major isoenzyme involved in the production of... |
acetaminophen;
CYP2E1; the toxic metabolite |
|
Ketorolac and Tromethamine are administered via _______.
Used for short term (up to ___ days) for treatment of..... Have a potential ______ to ASA and other NSAIDS in pts who have exhibited symptoms of _____, _____, _____, _____, _____ or ____ after exposure to NSAIDS |
IV/IM;
5; mod-severe acute pain requiring analgesia at the opioid level cross-sensitivity; asthma, rhinitis, urticaria, nasal polyps, angioedema, bronchospasm |
|
COX-1 is present in virtually _____ and is ___.
|
all cells; constitutive
|
|
PG's (prostaglandins) produced from COX-1 are involved in the maintenance of normal _____ functions.
|
physiologic
|
|
PGs function in the stomach by providing the gastric mucosal barrier through stimulating _____ and _____ secretion and mucosa _______.
|
mucous; bicarb;
mucosal blood flow |
|
PG's function in the kidney through _____ and _____.
They are vaso-______ which provide renal _______ by maintaining ____ and ____. |
PGE2; PGI2;
dilating; hemostasis; renal blood flow and glomerular filtration |
|
PG's function in hemostasis through ______ (platelets only contain this). Inhibition of this causes the effects of increased _____ and _____.
|
COX1;
GI bleeding; renal insufficiency |
|
COX2 is an inducible form in cells experiencing _________ but is considered to be constitutive in the ____ and _____.
Inhibition results in _____, ____ and ____ actions. |
inflammation; kidney; brain;
anti-inflammatory, analgesic, antipyretic |
|
Specific inhibition of COX2 may be a predisposition to ________.
Inhibition removes the ____ Effects and allows the pro-thrombic effects of _____ to predominated (disrupts the balance). |
thrombosis;
PGI2; TXA2 |
|
Celecoxib is a _____-specific inhibitor that was approved by the FDA but since, has concluded that all NSAIDS should be contraindicated in pts who are immediately post-op from ____ surgery.
|
COX2;
CABG |
|
Selective COX2 inhibitors are cross-reactive with ___ and _____ so need to avoid if known allergy to these.
|
ASA and all other NSAIDS
|
|
Selective COX2 inhibitors are contraindicated in pts with the _________.
|
asthma triad
|
|
Selective COX2 inhibitors have cross-reactivity with ____ drugs. Celecoxib is contraindicated in pts who have demonstrated allergic reactions to ______.
|
sulfa; sulfonamides
|
|
All NSAIDs have a significant risk of ____ toxicity.
Reserve COX2 inhibitors for pts at highest risk for ____________. Use with great caution or not at all in pts with ____, ____ and ___. |
GI;
NSAID-induced gastropathy; chronic renal failure, severe heart disease, hepatic failure |
|
COX2 inhibitor induced nephrotoxicity mechanism involves both direct toxic damage to the _____ and decreased ________ secondary to inhibition of renal ___ synthesis.
|
tubules; renal perfusion; PGs
|
|
COX2 plays a significant role in maintaining ______ in pts with compromised renal function; Therefore, selective COX2 inhibitors offer ___ advantage over nonselective NSAIDs with regard in renal safety in pts with decreased renal function.
Contraindicated in advanced _______ and use with caution in ____, ____ or ___. |
renal blood flow; no; renal disease; fluid retention, HTN, HF
|
|
COX2 inhibitors have a probability of a greater _______ effect compared to nonselective NSAIDS.
|
pro-thrombic
|
|
Celecoxib is the first drug to be approved for the tx of a hereditary form of colorectal cancer known as __________
|
familial adenomatous polyposis
|
|
All pts with a low risk of GI complications: ____ COX2 inhibitor.
|
no
|
|
For pts at high risk of GI bleeding, a nonselective ____ plus a ____ or _____ appears to be beneficial
|
NSAID; PPI; misoprostol
|
|
For pts on low-dose ASA, the ASA negates any ____ benefit of using a COX2 inhibitor.
|
GI benefit
|
|
AHA now recommends d/c all NSAIDS except ____ in MI pts and pts hospitalized for MI or UA
|
ASA
|
|
Pts with AF receiving either ASA or warfarin for stroke prevention should avoid using _________
|
NSAIDS
|
|
Naproxen is the preferred choice for pts with _____ or at high risk since it is considered to be safer for this system.
|
CV
|
|
First Generation antihistamines include: (6)
|
diphenhydramine, dimenhydrinate, chlorpheniramine, promethazine, cyproheptadine, hydroxyzine
|
|
Second generation antihistamine drugs include: (5)
|
terfenadine, fexofenadine, loratadine, desloratadine, catirizine
|
|
Terfenadine is a ________ drug, specifically a ___-drug, and has no __________ activity itself. Unchanged it can cause fatal _____ (______ and _____) when taken by pts with liver disease or concurrently with inhibitors of the P450 system
|
antihistamine; pro-; antihistaminic; arrhythmias; QT prolongation, torsades
|
|
Fexofenadine is the primary active metabolite of _______ which is a ____ drug
|
terfenadine; antihistamine
|
|
Desloratadine is the active metabolite of _____ which is a _____ drug.
|
loratadine; antihistamine
|
|
Catirizine is compared to ______ (a _____ drug) but has a ____ onset and causes more _____.
|
loratadine; antihistamine; faster; drowsiness
|
|
Promethazine has the highest ______ and ____ Activity; has high _____ activity, and has very high _____ effects.
|
antihistaminic; sedative; anticholinergic; antiemetic
|
|
Nonsedating antihistamines have mod/high _____ effects, low/no _____ effects, low-no _____ effects and no ____ effects.
|
antihistamine; sedative; anticholinergic; antiemetic
|
|
First generation antihistamines have variable amounts of activity with regard to ____ activity, _____, _____ effects, _____ activity and ______ activity (prevention of _____)
|
antihistaminic; sedation, anticholinergic; antipruritic; antiemetic (motion sickness)
|
|
Non-sedating antihistamines have _____ antihistaminic activity but little to no activity as ___, ____ or ____.
Have a ____ Duration of action, ___ onset, and do not penetrate the ____. |
high;
sedatives; anticholinergics; antiemetics; long; slow; BBB |
|
Which drug has the highest activity in all respects of antihistaminic drugs?
|
promethazine
|
|
Diphenhydramine is the _____ most active agent in all respects of antihistaminic drugs.
|
second
|
|
Hydroxyzine is a strong _____ and _______ antihistamine drug
|
sedative; antiemetic
|
|
Cyproheptadine has significant _______ Activity.
|
anti-serotonin
|
|
Which antihistamine can be used as an anti-pruritic?
|
hydroxyzine HCL
|
|
Which antihistamine can be used for the treatment of vertigo?
|
meclizine (antivert)
|
|
Which antihistamine can be used for the treatment of motion sickness and N/V?
|
dimenhydrinate (dramamine)
|
|
Oral antihistamines are used for _______ and ______ and for the treatment of a ____ and ____ due to the common cold.
Drug= _________ |
perennial/seasonal allergic rhinitis, vasomotor rhinitis;
runny nose and sneezing; chlorpheniramine |
|
Parenteral antihistamines are used as an adjunct to ___ and other measures in _______.
Drug= __________ |
Epi; anaphylaxis; diphenhydramine
|
|
Diphenhydramine is used for active and prophylactic treatment of ______.
Also has an anticholinergic effect in _________ disease. |
motion sickness;
parkinson's |
|
Promethazine is used for preop______, as an adjunct to _____ for control of postop pain, and for postop _____ effects.
|
sedation; opioid analgesics; antiemetic
|
|
Cyproheptadine is used off label to stimulate _________ (antihistamine)
|
appetite
|
|
Antihistamines may have additive/synergistic effects with CNS ________. Clinically significant for ___ generation agents.
Avoid concurrent use of _____ and Rx/OTC sources of ____ or _____. ______ may be considered minimally sedating. |
depressants; 1st;
alcohol; sedatives; tranquilizers; Cetirizine |
|
Continuous use of a ____ generation antihistamine is effective for the tx of seasonal and perennial allergic rhinitis.
|
2nd
|
|
What are the 2 preferred 2nd generation antihistamine agents preferred for the tx of allergic rhinitis? This is because they do not cause _____ at recommended doses.
|
fexofenadine, loratadine and desloratadine;
sedative |
|
Which agent/ route of administration is the most effective for controlling all sx of allergic rhinitis?
|
intranasal steroids
|
|
Which antihistamines are recommended as safe to use during pregnancy?
|
1st and 2nd
|
|
Antihistamines inhibit ______ reaction only and do not completely stop symptoms since other mediators are involved.
They reduce ____, _____, _____, and ____ but DO NOT reduce ________. 1st gen agents are ____ and cross the BBB causing ______. 2nd gen agents are less able to ______ and are non-_______. Anticholinergic effects are prominent with ___ generation agents. |
early phase;
sneezing, nasal pruritis, lacrimation and rhinorrhea; nasal congestion; lipophilic; sedation; cross the BBB; sedating 1st |
|
Intranasal steroids are the DOC for nasal ____ and also considered to be the first line-agents for moderate to severe _____.
Most effective tx for ______, ______, ____, ____ and ____. No ___ or ___ effects |
congestion; allergic rhinitis
nasal congestion, discharge, sneezing, post-nasal drip and pruritis; sedative or anticholinergic |
|
For the pharmacologic tx of osteoarthritis, tx is ____ and directed towards providing _______.
____ may be effective in many cases and is usually recommend as initial tx in max adult daily doses (<___g/day) _____ should be used if inflammatory component is present or if pain relief from above is inadequate |
empiric; sympathetic;
acetaminophen; 4; NSAIDS |
|
What two drug classes are the most successful for treating fibromyalgia?
|
antidepressants, anticonvulsants
|
|
Dual MOA antidepressants used for tx of fibromyalgia block reuptake of ____ and ____. (SNRI)
Drugs include: _____ and _____ |
NE; serotonin;
Duloxitine, Milnacipran |
|
Anticonvulsant used for fibromyalgia= ______.
|
pregabalin
|
|
Gout is always preceded by ________
|
hyperuricemia
|
|
Transient attacks of gouty arthritis are initiated by.......
|
crystallization of urates in and around joints
|
|
Tophi are...
|
large aggregates of irate crystals and the surrounding inflammatory response
|
|
Lesch-Nyham syndrome is a _____ disorder affecting only males in which _____ is totally absent
|
X-linked; HGPRT
|
|
What are the 4 clinical stages of Gout?
|
Asymptomatic hyperuricemia, acute gouty arthritis, inter critical gout, chronic tophaceous gout
|
|
Acute gouty arthritis (stage 2)= sudden onset of _________ with localized _____, _____ and _____.
Vast majority of first attacks are ______. May last for ___-____ if untreated and will gradually resolve. |
excruciating joint pain; hyperemia, warmth, extreme tenderness;
monoarticular; hours-weeks |
|
Intercritical period of gout (stage 3) is the ____ period between gout attacks.
Without therapy, this becomes ____ and attacks may become ______. |
asx;
shorter; polyarticular |
|
Renal manifestations of gout include: (3)
|
HTN, renal colic, chronic gouty nephrophathy.
|
|
Renal Colic is......
|
the passage of crystals and stones (uric acid stones)
|
|
Treatment for chronic gout includes blocking the synthesis of _____ with a ________ inhibitor such as ___ and ____.
Can also use _____ which increases the uric acid secretion (uricosuric agent) Or can use _______ for chronic gout refractory to conventional meds |
uric acid; xanthine oxidase; allopurinol and febuxostat;
probenecid; pegloticase |
|
For treatment for acute gout, want to block the entry of ____ into affected joints with a ______ disrupting agent to limit the inflammatory response.
Drug= ___________ Treat associated pain and inflammation with_____ or ______ (orally or intra-articularly) |
lymphocytes; micrtotubule;
cholchicine NSAIDs; corticosteroids |
|
ASA is contraindicated in acute gout attacks because salicylate competitively inhibits the .....
|
active tubular secretion of irate.
|
|
Acidic urine ______ urate crystallization. Want to maintain _____ urine through _____ and ______.
Continue this process until..... |
promotes; alkaline; liberal fluid intake; sodium bicarb
serum uric acid normalizes and tophaceous deposits disappear |
|
About ___% of the uric acid that is secreted into the urine gets reabsorbed.
|
80
|
|
Uricosuric agents prevent ______ of uric acid by blocking the active ____ and enhances _____
|
reabsorption; reabsorption; uric acid excretion
|
|
Probenecid is a ____ agent. Normal therapeutic doses inhibit the _____ of urate, thereby increasing the urinary _____ of uric acid and _____ the serum uric acid levels.
Initiate with small doses to avoid....... Stops urate _____ and promotes ______ of urate deposits (mobilization). *Maintain adequate ____ and ____ the urine |
uricosuric agent; tubular reabsorption; excretion; decreases;
dumping large amounts of irate into the urine and having possible stone formation deposition; reabsorption hydration; alkalinize |
|
Probenecid is contraindicated in pts with a history of _________
|
nephrolithiasis
|
|
For probenecid, do not want to start until an acute attack has ____. Therapy must be continued if already begun during an acute exacerbation.
Therapy may mobilize irate deposits in tissues and joints dumping large mounts of irate into the urine resulting in _____ formation. Concurrent use of _______ is contraindicated. Results in a net urate _____. |
subsided;
uric acid stone; salicylates; retention |
|
Anionic form of probenicid may competitively inhibit the active tubular secretion of other ________
Probenecid has beneficial interactions with ____. |
organic acids;
beta-lactams |
|
Pt information regarding use of probenicid includes:
-Avoid _____ -May take with __ or ___ for GI upset -Drink plenty of water to prevent.... -Must be taken _____ For therapeutic effect |
aspirin;
food; antacid; kidney stones; continuously |
|
Allopurinol is a ______ inhibitor. Is metabolized into its active metabolite _____. They both inhibit ______ which is needed to convert ____ to ____ and then to _____. This reduces the production of ____ without affecting the synthesis of vital purines
|
xanthine oxidase; oxipurinol (alloxanthine); xanthine oxidase; hypoxanthine, xanthine, uric acid;
uric acid |
|
Allergic skin reaction is common and can be severe with ____ use. Rash may be followed by .....
|
allopurinol;
severe hypersensitivity reactions |
|
Allopurinol may cause acute ______ in early stages probably due to......
Maintenance doses of _____ are gien for this |
gout attacks; mobilization of uric acid from tissue deposits;
colchicine |
|
Fluid intake to achieve urine output of >= ______ daily and avoidance of an acidic urine may prevent ______ during allopurinol use.
|
2L;
renal urate stones |
|
Pt should take allopurinol with ___ or ____ to avoid GI upset. Drink ___-___ glasses of fluids per day. Avoid agents which ____ the urine.
|
food; milk;
10-12; acidify |
|
Febuxostat is a _____ inhibitor that is selective for ________________.
|
xanthine oxidase; nonpurine XO
|
|
Febuxostat is indicated for ______ in pts with gout. Has drug interactions with medications metabolized by _____.
|
chronic management of hyperuricemia;
XO |
|
______ have occurred when therapy with Febuxostat was started. Prophylactic therapy is recommended with ____ or ____
|
Gout flares; NSAIDs, colchicine
|
|
Pegloticase is a recombinant ___________ which is a modified mammalian _____ (urate oxidase)
This oxidates uric acid to _____ (which is a water soluble purine metabolite) which results in lowering serum _____ levels. Indicated for ________ refractory to conventional tx in adults. |
polyethylene glycole (PGE); uricase;
allatoin; uric acid; chronic gout |
|
When using Pegloticase, need to premeditate with ____ and _____ to prevent infusion related and anaphylactic reactions.
Prophylactic administration of ____ or ____ is recommended starting 1 week before the first infusion and continuing for at least ____ months in order to prevent gout flare. |
antihistamines; corticosteroids;
NSAID or colchicine |
|
Colchicine binds to ____ (protein in microtubules) and prevents its _____ which causes:
-Inhibition of ___________ -Reduced _____ and diminished ____ response in deposited crystals -Blocks cell division by binding to ________ |
tubulin; polymerization
leukocyte migration; Phagocytosis; inflammatory mitotic spindles |
|
Cases of ____ have been seen in pts taking standard therapeutic doses of cochicine with interacting medications.
A substantially lower dose of colchicine was as effective as the higher dose previously used and was associated with... |
fatal colchicine toxicity;
significantly fewer ADR compared to the higher dose |
|
In pts with renal or hepatic impairment who are taking colchicine, don't want to give them _________ or _________
|
P-glycoprotin inhibitors; strong 3A4 inhibitors
|
|
Colchicine is used for relief of _____ with acute gout attacks and for regular ________ between attacks.
Often effective in ______ an attack when taken at the first sign of articular discomfort. |
pain; prophylactic use;
aborting |
|
Colchicine has severe GI effects including:
_____ is the most common and dose-limiting effect. ______ have been used to control this |
N/V/D and abdominal pain;
diarrhea; opiates |
|
Disease-modifying anti-rheumatic drugs (DMARDs) have the potential to ____ or ____ disease progression.
Nonbiological agents are ...... Biological agents are _______. |
slow; halt;
conventional DMARDs; anti-cytokines (biological response modifiers) |
|
Biological DMARDs that interact with the physiological actions of TNF-alpha= _____ and ______
|
etanercept; infliximab
|
|
Biological DAMRDs that antagonize actions of IL-1: _______
|
anakinra
|
|
Biological DMARDs that antagonize actions of IL-6: _________
|
tocilizumab
|
|
Glucocorticoids have potent ____ effects that diminish ___ and ____ associated with rheumatic diseases.
Usually reserved for _________ of active disease and for _____ tx while waiting for onset of DMARDs Also used in______ joints that experience flares. |
antiinflammatory; pain and swelling;
brief periods; bridge; isolated |
|
Conventional DMARDs are ___ Acting and must be started before ______ mechanical damage occurs.
Do not inhibit ___ and have no ____ or ____ activity. They ____ or ____ the progression of disease; They do not repair existing damage but may induce ___ and prevent _________. Have potential for serious _____. |
slow; irreversible;
Cyclooxygenase; analgesic or primary anti-inflammatory; halt/slow; remission; further injury; toxicity |
|
All patents with active RA should be candidates for ______
Also, any pt with signs and symptoms of a poor RA prognosis should receive a ____ as initial therapy since disease progression is most rapid........ |
DMARD; DMARD; in the first several years of active disease
|
|
What has been shown to be the most effective DMARD combination therapy?
|
SSZ plus MTX plus HCQ
|
|
Hydroxychloroquine (HCQ) is a _______ drug. Is a _____ agent which exerts anti-______ activity by inhibiting the release of IL-___.
Most effective in ___ disease Major-toxicity is a dose-dependent ______ |
DMARD; a anti-malarial; rheumatic; 1;
mild; retinopathy |
|
Gold salts are considered a _____ Drug. Are ingested by ___ and suppress ____ and ____ release and activity.
Most effective in pts with ______ who do no adequately respond to NSAIDs PO agent= ______ |
DMARD; macrophages; phagocytosis and lysosomal enzyme
mild RA Auranofin (*AU=gold) |
|
Sulfasalazine (SSZ) is an ________, ______ drug. Works by suppressing _______ cytokines (____ and ___)
May be DOC for pts with _____. |
immunomodulatory, DMARD;
pro-inflammatory; TNF, IL1 mild RA |
|
Methotrexate is a _____drug. Its MOA in RA is _____ but is thought to be similar to the anti-______ action (folate antagonist that inhibits synthesis of ____)
Major ADR include: -GI: (4) -Elevated serum _______ which if sustained, may have to ________. Can cause a ____ and _____. -Less common=________ Doses in RA are much lower than the doses used for _____ and severe toxicity is expected to be _________ |
DMARD; unknown; neoplastic; purines;
N/V/D/ stomatitis; transaminases; D/C and do liver biopsy; rash and pruritis; bone marrow suppression; cancer chemo; less frequent |
|
Leflunomide is the first oral agent for active ____ that is labeled for slowing disease progression. (______ drug)
MOA is through ________ that inhibits ____ synthesis. Also has ____ and _____ effects. Contraindications include the potential for immune ______, so is not recommended for pts with ______ or uncontrolled ____. Do not give ____ vaccines. |
RA; DMARD;
immunomodulatory actions; pyrimidine; antiproliferative; antiinflammatory; immune suppression; immunodeficiency; infections; live |
|
In Anti-cytokine agents, trials demonstrate RA improvement when ____ action is suppressed by agents which target ____ or _____
|
TNF; TNF or IL1
|
|
Anti-cytokine agents reduce signs and symptoms of ___, inhibit progression of ____ damage, and are more effective when combined with ____.
|
RA; structura; MTX
|
|
Etanercept is an _____ agent which is a soluble ____ receptor with high binding affinity for _______.
|
anti-cytokine; TNF; circulating TNF
|
|
Infliximab (anticytokine agent) is a __________ and is a chimeric monoclonal _____ that is directed against ____.
|
neutralizing ab; IgG; TNF
|
|
TNF inhibitors are recommended for pts with mod-severe disease who cannot tolerate ______ or have not responded to at least 2________
|
MTX; DMARDs
|
|
Do not use anti-cytokine agents in any pt with ______, hx of _____ or medical conditions predisposing them to infection.
|
active infx; Hx of recurrent infections
|
|
All three currently approved anti-cytokine agents have boxed warnings for an increased risk of serious _____, ____ and ___
|
infections, TB, sepsis
|
|
TNF antagonism is associated with an increased risk for reactivation of _____ and possibly other _______ infections. A positive ____ test requires prophylactic treatment before initiating ______ therapy
|
TB; opportunistic; TB skin; TNF antagonist therapy
|
|
Etanercept is a biologic response ______.
Is a ________ protein that is composed of extracellular ligand-binding portion of the _______ fused with the Fc domain of human _____. Is a dimeric soluble form of ____ which binds to _____ competitively inhibiting the binding of TNF to .......... When it binds to TNF, it blocks all interactions modulating the _____ and ____ responses induced by TNF. |
modifier;
recombinant fusion; TNF-receptor; IgG; TNF-R; TNF; to target cell surface receptors; inflammatory and immune responses |
|
Etanercept reduces signs and symptoms, inhibits progression of _____ and improves ______ in pts with mod-severe active _____. Can be sued in combination with _____.
|
structural damage; physical function; RA
MTX |
|
Etanercept has some serious side effects including a risk of serious ____ or _____.
Administration during ____ or any ____ infection is contraindicated. Also do not administer ____ vaccines. |
infections; death
sepsis; active; live |
|
Infliximab is a _____ Drug.
Is a chimeric monoclonal _____ antibody that binds with high affinity and specificity to ____. Indicated for moderate to severe _____. When used in combination with _____, reduces signs and symptoms, inhibits progression of ____ and improves _______ in patients. |
anti-cytokine;
IgG; TNF; RA; MTX; structural damage; physical function |
|
Infliximab showed a higher incidence in mortality and hospitalization for worsening of _____ in stages ___-___.
Contraindicated to use doses more than _____. |
HF; III-IV;
5 mg/kg |
|
Do not administer infliximab to pts with active ____ and discontinue if a _______ developed. Do not administer concurrent _______.
Worldwide, most serious ADR is ______ and its important to evaluate for this before hand. |
infection; serious infection;
live vaccines; TB |
|
Concurrent use of etanercept or anakinra with Infliximab has been associated with.....
|
an increased risk of serious infections and neutropenia
|
|
Anakinra is a ____ receptor antagonist. Binds and blocks the binding of ___ to target cells. This results in a decreased ___, _____ and ______.
|
IL-1; IL-1; inflammation; pannus formation; bone resorption
|
|
Anakinra is indicated for the reduction in signs and symptoms and to slow the progression of structural damage of mod-severe _____ in pts who have.......
Can be used alone or in combination with... Do not use concurrently with ______ agents, do not initiate in pts with _____ and d/c if a ______ develops and do not administer ________. |
RA; failed therapy with >=1 DMARD
DMARD; TNF neutralizing agents; active infections; serious infections; live vaccinations |
|
Abatacept is a _____ modulator which inhibits _______.
Do not use concurrently with ______ due to increased incidences of....... If a serious infection develops, need to ____ and _______. Do not give ______ concurrently or within 3 months after D/C use. ADR: ______ and ______ |
costimulation; T-cell activation;
TNF antagonists; infections and serious infections; D/C and test for TB live vaccines; serious infections and malignancies |
|
Rituximab is a chimeric ____/human recombinant monoclonal Ab directed against the _____ antigen found on the surface of normal and malignant _____.
Net effect is to....... Indicated in combination with ____ to reduce signs and symptoms of mod-severely active ____ who had an inadequate response to one or more ___________. Premedicate with _______ 30 min prior to each infusion. Boxed warnings include (2) |
murine; CD20; B cells;
deplete the population of immature and mature B cells that have CD20 on their surface; MTX; RA; TNF antagonists methylpredinsolone; fatal infusion reactions; severe mucocutaneous reactions |
|
Tocilizumab is a recombinant humanized monoclonal Ab that blocks the ____ receptor.
Indicated for treatment of pts with mod-severe active ____who have had an inadequate response to one or more _____ |
IL-6;
RA; TNF blockers |
|
What two types of medications can be used to treat asthma?
|
bronchodilators and antinflammatories.
|
|
Bronchodilators include ...(3)
|
beta adrenergic agonists, anticholinergics and theophylline
|
|
What are the 6 types of anti-inflammatory drugs used to treat asthma?
|
phospholipase A2 inhibitors, mast cell inhibitors, lipoxygenase inhibitor, leuktotriene receptor antagonist, monoclonal Ab to IgE, and short-acting beta2 agonists
|
|
Short acting beta2 agonists are used to relieve ______ symptoms associated with asthma.
|
acute
|
|
Phospholipase A2 inhibitors are ______ that are used to treat asthma.
|
steroids
|
|
Mast cell inhibitors used to treat asthma include: (1)
|
cromolyn sodium
|
|
Lipoxygenase inhibitors used to treat asthma include: (1)
They function to decrease the production of _____ which trigger inflammation and ____. |
Zileuton; leukotrienes, bronchoconstriction
|
|
Leukotriene receptor antagonists used to treat asthma include: (2)
They function to..... |
zafirlukast, montelukast;
block actions of leukotrienes |
|
What is the monoclonal Ab to IgE that is used to tx asthma?
|
omalizumab
|
|
Bronchodilators can either be ______ onset and ____ acting; or _____ onset and ____ acting.
|
immediate; short;
delayed; long |
|
Immediate onset and short acting beta2 adrenergic agonists stimulate the beta2 receptors in the lung causing ______
Drugs include: (3) |
bronchodilation;
epinephrine; isoproterenol; albuterol |
|
Epinephrine (as a bronchodilator) is nonselective for _____ and _____
|
beta1; beta2
|
|
Isoproterenol (as a bronchodilator) is nonselective for _____ and ____
|
beta1; beta2
|
|
What is the DOC (bronchodilator) for the treatment of asthma? What is it selective for?
|
albuterol; beta2
|
|
Indications for short-acting beta2 agonists include for acute attacks of ______ including _________. Treat this with _____ and ____.
Also indicated for the prevention of ________ (drug=_______) |
bronchospasm; status asthmaticus;
albuterol, epi; exercise induced bronchospasm; albuterol |
|
Beta2 agonists can cause ____ if enough systemic absorption occurs (of the short-acting beta agonists) casing ________
|
vasodilation; reflex tachycardia
|
|
Epi can cause _____ and ______ because it directly stimulates _____ along with beta2.
|
tachycardia and palpitations; beta1
|
|
Short-acting beta2 agonists can cause tremors because they can stimulate beta2 receptors in the ________
|
skeletal muscle
|
|
Long acting beta2 agonists are no longer used to treat asthma in adults and children because when they are taken without an inhaled steroid, they have been shown to increase the risk of.....
|
even more severe attacks and death
|
|
Salmeterol is a ________ and is indicated for the prevention of......
Not indicated for.... Boxed warning: increased __________ was seen in clinical studies when subjects received LABAs in addition to their regular asthma medication |
long acting beta2 agonist; exercise induced bronchospasm;
tx of acute attacks; asthma-related deaths |
|
Formoterol is a ____ onset _____ drug when compared to salmeterol. Is more convenient for _____ with administration 15 min before ____.
|
faster; LABA; exercise-induced asthma; activity
|
|
Theophylline is classified as a ________ but may have a more important effect as an ___________ agent affecting the late asthmatic response.
Drug has a narrow therapeutic index requiring..... |
bronchodilator; anti-inflammatory immunomodulating
monitoring |
|
Factors which increase the half-life of theophylline include drug interactions with....
Example drugs include: (3) |
P450 inhibitors;
cimetidine, erythromycin, ciprofloxacin |
|
At therapeutic levels, theophylline can cause ____, ____ and____.
Over 20 mg/L it can cause ____,_____, ____, ____and ____ Over 30 mg/L it can cause ____ and _____ |
nausea, nervousness, anxiety;
nausea, insomnia, tremor, anxiety, tachycardia; arrythmias, seizures |
|
Indications for theophylline inclue moderate to severe ________
Also used as a second line agent in _____ (no firm evidence that increases effects of B2A;s) .IV forms have been considered ineffective in _______. |
chronic asthma;
acute asthma; status asthmaticus |
|
status asthmatics is....
|
an acute asthma attack that doesn't respond to standard treatments of bronchodilators and steroids
|
|
Stimulation of parasympathetic muscarinic receptors in the lungs activates _____ which increases ____ and results in ______
This is blocked by ______. Drug: (1)..... |
guanyl cyclase; cGMP; bronchconstriction;
anticholinergics; Ipratropium |
|
Ipratropium is a _____ drug that is indicated as a ______ for maintenance treatment of ______ associated with COPD. Primary use of this class of drugs is in ____ and ____
|
anticholinergic; bronchodilator; bronchospasm;
chronic bronchitis; emphysema |
|
Steroids decrease the synthesis and prevent release of _______, decrease activation of ______ and decrease vascular _____
|
chemical mediators; inflammatory; permeability
|
|
Systemic steroids should be initiated in any pt requiring ______ for acute asthma.
IV drug= ________ Indicated for the treatment of _______. |
hospitalization;
Methylprednisolone; status asthmaticus |
|
TOC for acute severe asthma exacerbations=
|
early aggressive use of systemic steroids and aerosolized beta2 agonists
|
|
Inhaled steroids are used for the long-term treatment of ____ in asthma patients. They are used for management of pts progressing to _________ and are NOT indicated for....
|
inflammation;
persistant asthma; relief of acute bronchospasm |
|
Inhaled steroid drugs used: (4)
|
beclomethasone;
Fluticasone/salmeterol (advair); Budesonide/formoterol (symbicort); mometasone/formeterol (dulera) |
|
Advair diskus (drugs included):
|
fluticasone
salmeterol |
|
Symbicort (drugs included):
|
budesonide;
formoterol |
|
Dulera (drugs included):
|
mometasone;
formoterol |
|
Pt counseling when prescribing steroids for asthma includes that they are to be used for _____ and not _______; as well as not to D/C abruptly because it may cause.....
|
chronic disease; acute attacks;
severe asthma exacerbations |
|
Cromolyn sodium is used in the prevention of ________. There is no role for it in the treatment of _____.
|
exercise-induced asthma; acute asthma
|
|
Cromolyn works by binding to ______, blocking the entry of ____ and stabilizing the membranes. This causes prevention of ____ and ______.
Also causes the opening of ____ channels causing an influx and _ __________. This results in the inhibition of the activation of....... |
mast cells; calcium ions; rupture and degranulation;
chloride; hyperpolarizaton; several cell types |
|
Leukotrienes causes ___ and ____ migration, increase capillary _____, and ____ contraction.
This results in _____, ___ and ____ |
neutrophil; eosinophil;
permeability; visceral smooth muscle; inflammation, edema, bronchoconstriction |
|
Zileuton is inhibits _____ and inhibits _____ formation.
Indicated for prophylaxis and _____ Treatment of asthma in adults and children >__years. Is intended for continuous use in chronic therapy and to continue taking during........Also, do not use to treat ______ |
5-lipoxygenase; leukotriene
chronic; 12; symptom-free periods; acute attacks |
|
Zileuton is a ____ inhibitor
|
lipoxygenase
|
|
Zafirlukast and montelukast are ________ antagonists
|
leukotriene receptor
|
|
Zafirlukast is a selective and competitive leukotriene receptor antagonist of leukotrienes ____ and ____
Indicated for prophylaxis and chronic treatment of _____ in adults and children > ___ years. Take on a..... Intended for continuous use even during _________ and not for ______ |
D4 and E4;
asthma; 5; empty stomach asx periods; acute attacks |
|
Montelukast selectively inhibits the ______ leukotriene receptor blocking the actions of ______ here with no agonist activity.
Dosing is _________ for asthma or asthma combined with _____, taken with or without ____ Intended for use even during ______ and not for ______ |
cysteinyl; LTD4;
Once daily in the evening; allergic rhinitis; food asx periods; acute attacks |
|
Antileukotriene agents are not useful for ____ and must be taken continuously to.....
|
acute attics; derive benefit
|
|
Omalizumab is a monoclonal Ab to _____. Binding does not occur at the variable allergen specific Fab site so.....
Administered ____ once every ____. Indicated for use in pts over ____ with mod-severe persistent ____ whose symptoms have not been adequately controlled with _______. |
IgE;
all allergen induced responses are inhibited regardless of allergen specificity. SC; 2-4 weeks. 12; asthma; inhaled steroids |
|
Omalizumab carries a risk of _____ which may occur anytime from soon after the first dose to more than a year after the start of regularly scheduled treatments. Need to observe for at least ______ post-dose
|
anaphylaxis; 2
|
|
Antitussives work centrally to increase the __________ of the medullary cough center by decreasing _____________.
Optiate antitussives include ____ and ____ Nonopiate antitussives include ____ |
threshold for stimulation; sensitivity to afferent impulses
codeine, hydrocodone; dextromethorphan |
|
Antitussives work peripheral to decrease the __________ through a topical local _____ effect.
Drug: (1) |
sensitivity to irritant receptors; anesthetic;
benzonatate (tessalon perles) |
|
Codeine is an effective antitussive at doses that are not ____, do not cause ______ and are not likely to result in _____.
|
analgesics; respiratory distress; abuse
|
|
Hydrocodone is very similar to _____ but somewhat more ______. Available as antitussive only .......
|
codeine; habituating; in combination with other ingredients
|
|
Dextromethorphan causes minimal ______, has no ____ effects.
___ Isomer used therapeutically and is structured similarly to ___ but does not...... Elevates the ____ For coughing, should not be _____ at normal doses |
CNS depresson; analgesia/nonopiate;
D; codeine; interact with opioid receptors; threshold; addicting |
|
____ sensations and ____ can be produced when high doses of Dextromethorphan are ingested.
|
euphoric; hallucinations;
|
|
"Serotonin syndrome" may result if using dextromethorphan with __________ causing ____, ____ and ______
|
MOA inhibitors; hypotension, fever, muscle regidity
|
|
Tx of acute cough due to common cold=
_____ antihistamines are ineffective; |
1st gen antihistamine/decongestant combinations;
nonsedating |
|
Tx of a cough due to acute bronchitis=
|
short acting inhaled beta2 agonists if wheezing
|
|
Tx of a cough due to chronic bronchitis=
|
ipratropium, SABA for bronchospasm and dyspnea, antitussive for persistent cough despite other tx
|
|
Tx of a cough due to acute exacerbation of chronic bronchitis:
|
ipratropoum, SABA, or combo
oral steroid for 10-15 days |
|
Do not use cough and cold medications in children under age _____
|
4
|
|
Expectorants facilitate the removal of ______ by decreasing ______.
Only currently used agent is _______ |
viscous mucus;
mucus viscosity; Guaifenesin |
|
Mucolytics decrease sputum _____, ______ thickened mucus secretions and facilitates _______.
Drug=_______ Also used as an antidote for ___________ |
viscosity; liquefies; expectoration;
acetylcysteine; acetaminophen poisoning |